Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Katherine Perez, PhD
Pfizer, Inc.
Disclosure(s): No financial relationships to disclose
Poster(s):
(P-1507)
In Vitro
Activity of Ceftazidime-avibactam against Enterobacterales Isolates Producing Multiple β-lactamases Collected Globally as a Part of the ATLAS Global Surveillance Program from 2018-2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1508)
In Vitro
Activity of Aztreonam-avibactam against Enterobacterales Isolates Producing Multiple β-lactamases Collected Globally as a Part of the ATLAS Global Surveillance Program from 2018-2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1509)
In Vitro
Activity of Aztreonam-Avibactam Against Enterobacterales Isolated from Pediatric and Adult Patients Collected During the ATLAS Global Surveillance Program, 2018-2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1510)
In Vitro
Activity of Ceftibuten-Avibactam and Comparator Agents Against Enterobacterales Collected Globally as Part of the ATLAS Surveillance Program, 2022 by Region
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
